Adverse environmental conditions influence age-related innate immune repsonsiveness by May, Linda
BioMed CentralImmunity & Ageing
ssOpen AcceResearch
Adverse environmental conditions influence age-related innate 
immune responsiveness
Linda May1, Anita HJ van den Biggelaar1,2, David van Bodegom1, 
Hans J Meij1, Anton JM de Craen1, Joseph Amankwa3, Marijke Frölich4, 
Maris Kuningas1 and Rudi GJ Westendorp*1,5
Address: 1Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands, 2Cell Biology Division, Telethon 
Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Perth, Australia, 3Ghana Health Service, 
Upper East region, Bolgatanga, Ghana, 4Department of Clinical Chemistry, Leiden University Medical Center, Leiden, the Netherlands and 
5Netherlands Consortium for Healthy Ageing, Leiden, the Netherlands
Email: Linda May - l.may@lumc.nl; Anita HJ van den Biggelaar - anitav@ichr.uwa.edu.au; David van Bodegom - d.van_bodegom@lumc.nl; 
Hans J Meij - j.j.meij@lumc.nl; Anton JM de Craen - craen@lumc.nl; Joseph Amankwa - jaamankwa@yahoo.com; 
Marijke Frölich - m.frolich@lumc.nl; Maris Kuningas - m.kuningas@lumc.nl; Rudi GJ Westendorp* - r.g.j.westendorp@lumc.nl
* Corresponding author    
Abstract
Background-: The innate immune system plays an important role in the recognition and induction
of protective responses against infectious pathogens, whilst there is increasing evidence for a role
in mediating chronic inflammatory diseases at older age. Despite indications that environmental
conditions can influence the senescence process of the adaptive immune system, it is not known
whether the same holds true for the innate immune system. Therefore we studied whether age-
related innate immune responses are similar or differ between populations living under very diverse
environmental conditions.
Methods-: We compared cross-sectional age-related changes in ex vivo innate cytokine responses
in a population living under affluent conditions in the Netherlands (age 20–68 years old, n = 304)
and a population living under adverse environmental conditions in Ghana (age 23–95 years old, n
= 562).
Results-: We found a significant decrease in LPS-induced Interleukin (IL)-10 and Tumor Necrosis
Factor (TNF) production with age in the Dutch population. In Ghana a similar age-related decline
in IL-10 responses to LPS, as well as to zymosan, or LPS plus zymosan, was observed. TNF
production, however, did not show an age-associated decline, but increased significantly with age
in response to co-stimulation with LPS and zymosan.
Conclusion-: We conclude that the decline in innate cytokine responses is an intrinsic ageing
phenomenon, while pathogen exposure and/or selective survival drive pro-inflammatory responses
under adverse living conditions.
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The innate immune system plays a key role in the first line
recognition and clearance of pathogens, whilst orchestrat-
ing down-stream adaptive immune responses. An ade-
quate innate immune response consists of a delicate
balance between pro-inflammatory responses that facili-
tate pathogen clearance, and counteracting anti-inflam-
matory responses that control excessive systemic
inflammatory host responses [1-4]. Ageing is associated
with an impaired capacity of the innate immune system to
produce pro- as well as anti-inflammatory cytokines [5,6],
which weakens the ability to respond to infections and
cancers and has been associated with increased mortality
in the elderly [7]. Besides genetic and intrinsic factors, this
senescence process of the innate immune system could be
environmentally driven.
As far as the adaptive immune system is concerned, there
are indications that a high versus low exposure to infec-
tious pathogens influences the ability to produce type-1
and type-2 T helper cell cytokine responses [8]. In addi-
tion, there is accumulating evidence that chronic infec-
tions, such as with CMV [9], contribute to the age-related
decline in T cell cytokine responses. Besides changes in the
T cell compartment itself [10], alterations in the innate
immune system may be responsible for this observed var-
iation in T cell responsiveness. There are indications that
chronic infections, such as with helminths, can modulate
Toll-like receptor (TLR)-mediated innate immune
responses [11,12], and mouse studies have provided evi-
dence for a decline in innate immune responses with
increasing age [13,14]. However, the role of environmen-
tal conditions in age-related changes in innate immune
responses has not been assessed before. We suggest that in
line with observations for T cell responses, persistent
immune challenges will accelerate the senescence of the
innate immune system in populations experiencing life-
long exposure to infections. However, as we have hypoth-
esized previously, infectious pressure may not allow lower
immune responsiveness, and this enhanced age-related
decline in innate immune responses may for that reason
be distorted by a selective survival of individuals produc-
ing strong pro-inflammatory immune responses [15].
The aim of this study was to compare differences in cross-
sectional age-related changes in inflammatory immune
responses in two populations living under very different
environmental conditions: one population born and
raised under affluent conditions in the Netherlands; the
other population living under lifelong strong adverse con-
ditions in a remote area of the Garu-Tempane district in
Ghana. For this reason we studied the production capacity
of ex vivo-induced levels of the pro-inflammatory cytokine
Tumor Necrosis Factor (TNF) and anti-inflammatory
cytokine Interleukin (IL)-10 in both populations.
Results
The Dutch study population consisted of 304 adults, of
which 138 were male and 166 were female, with an age-
range of 20–68 years (median age is 35 years). The Gha-
naian study population consisted of 562 adults, 59 males
and 503 females, and with an age-range of 23–95 years
(median age is 48 years) were significantly older than the
Dutch study population (p < 0.001).
In the Dutch study population the ex vivo LPS-induced
production of TNF (median is 6878, pg/ml; IQR 5379 –
9431) and IL-10 (median is 2201 pg/ml; IQR 1776 –
2703) was significantly lower compared to the Ghanaian
population (TNF: median is 12532 pg/ml; IQR 7789 –
18979, p < 0.001) (IL-10: median is 4370 pg/ml; IQR
3151 – 5967, p < 0.001)). In addition, in response to
zymosan or LPS/zymosan co-stimulation the Ghanaian
population produced median TNF levels of 12599 pg/ml
(IQR 8504 – 18281) and 14597 pg/ml (IQR 8704 –
20757), and median IL-10 levels of 210 pg/ml (IQR 121
– 360) and 581 pg/ml (IQR 354 – 941), respectively.
A significant age-related decrease in ex vivo LPS-induced
production of both IL-10 and TNF was observed in the
Dutch study population (Table 1 and Figure 1). Similarly,
among Ghanaian adults ex vivo LPS-induced IL-10 pro-
duction decreased with age (Table 1 and Figure 2). This
was, however, not observed for LPS-induced TNF produc-
tion, which remained unchanged with increasing age. The
age-related decrease in IL-10 responses in the Ghanaian
study population was not different to that in the Dutch
population (p for interaction = 0.202), whereas that of
TNF was (p-int = 0.067). Also in response to zymosan and
LPS/zymosan stimulation, IL-10 production significantly
decreased with age in the Ghanaian study adults. TNF pro-
duction remained unchanged in response to zymosan but
increased significantly in response to LPS/zymosan co-
stimulation (Table 1 and Figure 2).
As males were underrepresented in the Ghanaian study
population we repeated our analysis by selecting for
women only. In line with findings for the total study pop-
ulation, IL-10 production decreased with age in response
to all stimuli (LPS: -0.061 SD per 10 years, (SE = 0.029), p
= 0.039; zymosan: -0.129 SD per 10 years (SE = 0.029), p
< 0.001; LPS/zymosan: -0.101 SD per 10 years (SE =
0.030), p = 0.001) in the group of Ghanaian women, and
similar patterns were observed for TNF production (LPS: -
0.002 SD per 10 years (SE = 0.029), p = 0.94; zymosan: -
0.024 SD per 10 years (SE = 0.030), p = 0.43; LPS/
zymosan: 0.064 SD per 10 years (SE = 0.031), p = 0.039).
Also for women in the Dutch study population, similar
patterns were observed as in the total population: IL-10
changed -0.161 SD per 10 years (SE = 0.061) (P = 0.009)
and TNF changed -0.121 SD per 10 years (SE = 0.051) (pPage 2 of 7
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and the Ghanaian study population, we repeated the anal-
yses of the Ghanaian sample, restricting to participants for
the same age range as in the Dutch sample (22 to 68
years). Here similar results were observed for IL10 produc-
tion upon stimulation with LPS (-0.100 [0.036], p =
0.005), zymosan (-0.199 [0.035], p < 0.001) and LPS/
zymosan (-0.154 [0.036], p < 0.001). Also for TNF similar
results were observed upon stimulation with LPS (0.005
[0.036], p = 0.89), zymosan (-0.026 [0.037], p = 0.48) and
LPS/zymosan (0.067 [0.038], p = 0.077).
Discussion
In this study we have shown that in an adult Dutch popu-
lation that lived under affluent conditions for their entire
life, there is a gradual decline in the production of ex vivo
LPS-induced anti-inflammatory IL-10 as well as pro-
inflammatory TNF response with increasing age. A similar
decline in IL-10 production was observed in the Ghanaian
adults that have experienced a lifelong exposure to infec-
tious pathogens. In contrast TNF responses to LPS
remained unchanged and in response to co-stimulation
with LPS and zymosan TNF production even significantly
increased with age among Ghanaians.
There are several possible explanations for these data, as
an age-related decline in the cytokine production capacity
of the innate immune system may be intrinsically regu-
lated, environmentally driven or be a result of selective
survival. First, we believe that in the Dutch study popula-
tion that lives in an affluent environment with low infec-
tious exposure and where mortality rates up to the age of
80 years are low, intrinsic age-related effects play a pivotal
role and explain the age-related decline in cytokine pro-
duction. This includes an age-related lower expression of
Toll-like receptors [16] and impaired function of all cells
of the innate immune system [17-19] that together results
in a lower production capacity of cytokines. We propose
that the same intrinsic mechanism of senescence of the
innate immune system would act in the Ghanaian popu-
lation.
Second, it is possible that in the Ghanaian population
continuous pathogen exposure accelerates ageing of the
innate immune system. Although this hypothesis is yet to
be proven, there are several indications that chronic infec-
tions can modulate innate immune function, including
findings that chronic helminthic infections reduce TLR2
expression[11] and our own observations that LPS-
induced TNF and IL-10 responses were significantly
enhanced in the Ghanaian compared to Dutch study pop-
ulations. Interestingly, in patients with chronic Hepatitis
C Virus (HCV) infections, the over-production of pro-
inflammatory cytokines, in particular TNF has been
shown to be likely due to a loss of TLR tolerance, a protec-
tive mechanism usually in place to limit inflamma-
tion[20]. In mice it has been shown that with age this
tolerance process is attenuated[13]. Considering that TNF
responses remained unchanged or increased with age in
the Ghanaian population, we propose that if anything,
our data do not support the hypothesis that a lifelong
exposure to infections accelerates the age-related decline
Age-related pro- (TNF) and anti-inflammatory (IL-10) cytokine responses in the Dutch study population (n = 304)Figu  1
Age-related pro- (TNF) and anti-inflammatory (IL-10) cytokine responses in the Dutch study population (n = 
304). Data represent cytokine production upon ex vivo stimulation with LPS and are expressed as z-scores with standard 
errors indicating the deviance from the population mean (zero-value). P-values indicate a trend in cytokine production over 
age.Page 3 of 7
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Age-related pro- (TNF) and anti-inflammatory (IL-10) cytokine responses in the Ghanaian study population (n = 562)Figu  2
Age-related pro- (TNF) and anti-inflammatory (IL-10) cytokine responses in the Ghanaian study population (n 
= 562). Data represent cytokine production upon ex vivo stimulation with LPS and are expressed as z-scores with standard 
errors indicating the deviance from the population mean (zero-value). P-values indicate a trend in cytokine production over the 
age.
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drive pro-inflammatory responses.
Third, the age-related changes in cytokine production
observed in the Ghanaian population may reflect the
selective survival of individuals with immune responses
that promote survival in adverse environmental condi-
tions [21,2,22]. Previously, we have hypothesized that
under adverse conditions people with enhanced pro-
inflammatory immune responses may have greater sur-
vival potential than those with stronger anti-inflamma-
tory responses [15]. This may explain why IL-10 but not
TNF responses decline with age in Ghana.
Inflammation has been suggested to be one of the mech-
anisms underlying pathogenesis of several age-associated
diseases such as cardiovascular disease [23]. Considering
the emerging epidemic of chronic diseases in low-income
countries [24], we therefore propose that this could well
be explained by the here observed increase in pro-inflam-
matory versus decrease in anti-inflammatory responses in
older age groups resulting from overstimulation or selec-
tive survival for this pro-inflammatory response pattern.
To our knowledge this is the first study looking at age-
related changes in innate immune responses in popula-
tions aging under very diverse environmental conditions.
A drawback of this study is that for the Dutch study pop-
ulation we did not have data in response to TLR ligands
other than LPS. However, given the same patterns to dif-
ferent ligands in Ghana, we would expect no remarkable
differences. In further research it should be tested whether
the same trends will be observed in the Dutch population.
Also age ranges were not completely alike including par-
ticipants with a larger age-range in the Ghana population
than in the Dutch cohort. Also there might be some uncer-
tainty concerning the age of the participants in the highest
age-category in the Ghanaian population, as these were
perceived ages estimated based on face-value, life-history
and mobility. We therefore grouped them as 60 plus. In
addition, due to the cross-sectional nature of the study, we
can not draw any final conclusions whether age-related
changes in cytokine production is indeed an intrinsic phe-
nomenon occurring over age, a result of selective survival
and/or pathogen exposure.
In conclusion, in this study we demonstrated for the first
time that in both in affluent and adverse environmental
conditions there is an age-related decline in the IL-10 pro-
duction capacity of the innate immune system. For TNF
production, a similar decline was observed under affluent
environmental conditions, but not under adverse envi-
ronmental conditions. Lower production of cytokines
seems an intrinsic phenomenon of the ageing process
whereas chronic infections and/or selective survival may
drive cytokine production towards pro-inflammatory
responsiveness.
Methods
Populations
The Ghanaian part of our study was conducted in the
remote Garu-Tempane district in the Upper-East region of
Ghana. This densely populated agricultural area is inhab-
ited by several tribes, mostly Bimoba and Kusasi. The
Ghana Upper-East region, and especially the Garu-Tem-
pane district, is underdeveloped, poor and mortality rates
are high, with main causes of death including malaria,
diarrhoea and poor nutrition [25,26]. The vast majority of
the people are farmers and the total agricultural process is
done by hand labor. In 2001, we mapped the research
area using a GPS system[27]. Since 2002, we have revis-
ited the area annually to assess population changes. In
2006 a series of whole-blood assays were taken from a
subset of the population. The Dutch study population
consisted of subjects enrolled in a study on heritability of
cytokine production in twins[28]. All people were born
and raised in the Netherlands. A main difference between
the general Ghanaian and Dutch population is mortality
rates, that in the Netherlands results in a demographic
composition with a median age is 39 years[29], whereas
in the Garu-Tempane district this is 14 years. The Medical
Ethical Committee of the Ghana Health Service, as well as
the Medical Ethical Committee of the Leiden University
Medical Center approved the studies. Witnessed observed
informed consent was obtained from all Ghanaian partic-
ipants and written informed consent was obtained from
the Dutch participants.
Whole blood stimulation assay and cytokine production
In both of these populations pro-inflammatory and anti-
inflammatory cytokine production capacity was assessed
by stimulating ex vivo whole blood samples with lipopol-
ysaccharide (LPS) as described elsewhere[30,31]. All
venous blood samples were drawn in the morning to
exclude circadian variation, diluted twofold with RPMI-
Table 1: Age-dependent decrease of cytokine production
Dutch Ghanaian
(n = 304) p-value (n = 562) p-value
Change in IL-10 production per 10 years of age (SE)
LPS -0.117 (0.045) 0.009 -0.053 (0.029) 0.064
Zymosan n.d. -0.116 (0.029) < 0.001
LPS/zymosan n.d. -0.081 (0.029) 0.006
Change in TNF production per 10 years of age (SE)
LPS -0.089 (0.041) 0.030 -0.004 (0.028) 0.89
Zymosan n.d. -0.025 (0.029) 0.39
LPS/zymosan n.d. 0.067 (0.030) 0.026
All analyses were adjusted for sex. Estimates indicate the increase in 
z-scores with standard error per 10 years of age. n.d. not determinedPage 5 of 7
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with medium alone or with an optimal dose of 10 μg/ml
E. coli-derived LPS (Sigma Aldrich, Zwijndrecht, the Neth-
erlands) in 24-well plates at duplicate volumes of 1 ml for
24 hours in 37°C incubators. In the Ghanaian sample,
additional ex vivo whole blood stimulations were per-
formed with 100 μg/ml zymosan and with a combination
of 10 ng/ml LPS and 100 μg/ml zymosan (Sigma-Aldrich,
Schnelldorf, Germany). Procedures and conditions were
kept similar in both settings, except that a CO2 incubator
set at 5% was used in the Netherlands, and ambient CO2
levels were induced by a candle jar incubation system in
Ghana[32]. In the candle jar incubation system culture
plates are placed in an airtight container with a burning
candle enclosed, and transferred as a whole to a 37°C
incubator once the candle has faded. The compatibility of
both systems was compared in a small experiment in
which whole blood assays were performed for the same
five staff members at both study sites: LPS-induced levels
of TNF and IL-10 were comparable for the ambient CO2
conditions in Ghana and the incubator set 5% CO2 condi-
tions in the Netherlands (data not shown). Supernatants
were collected and kept at -20°C in Ghana until trans-
ported on dry ice to the Netherlands.
In the Netherlands all samples were stored at -80°C until
cytokine levels were determined by ELISA. Cytokine ELISA
for human TNF and IL-10 were performed according to
manufacturers' guidelines (Central Laboratory of the
Blood Transfusion Service, Amsterdam, the Netherlands),
with detection limits of 4.0 pg/ml and 3.0 pg/ml respec-
tively.
Statistical analysis
All cytokine levels were ln-transformed, since they were
not normally distributed, and converted into z-scores
((individual level – mean level)/SD), which were used in
all analyses. Associations between cytokine responses and
age categories of 10 years as a continuous independent
variable were assessed with sex adjusted linear regression.
Calculations were performed with SPSS version 14.0
(SPSS Inc., Chicago, Illinois, USA).
Abbreviations
IL-10: Interleukin-10; TNF: Tumour Necrosis Factor; LPS:
lipopolysaccharide; SE: standard error.
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